Alan K. Davis

6.6k citations

112 papers · 4.4k indexed · 4 hit papers · h-index 31

Impact in

Clinical Psychology top 0.2%
- Psychedelics and Drug Studies
Biological Psychiatry top 1%

Papers in

Clinical Psychology 79
- Psychedelics and Drug Studies 64
Toxicology 10
- Forensic Toxicology and Drug Analysis 10

Co-authors: Roland R. Griffiths Frederick S. Barrett Matthew W. Johnson Nathan D. Sepeda Rafael Lancelotta Mary P Cosimano Patrick H. Finan Harold Rosenberg
Journals: Journal of Psychoactive Drugs (15 papers)Addictive Behaviors (8 papers)Journal of Psychopharmacology (6 papers)Psychology of Addictive Behaviors (4 papers)Addiction Research & Theory (4 papers)
Partner nations: United States Canada Netherlands

In The Last Decade

Alan K. Davis

105 papers receiving 4.3k citations

Hit Papers

align trajectories log scale

Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up 2022 · 245 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 Journal of Psychopharmacology
2021 Translational Psychiatry
2020 JAMA Psychiatry
2019 Journal of Contextual Behavioral Science

Peers

Countries citing papers authored by Alan K. Davis

Since Specialization

Citations

This map shows the geographic impact of Alan K. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan K. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan K. Davis more than expected).

Fields of papers citing papers by Alan K. Davis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan K. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan K. Davis. The network helps show where Alan K. Davis may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Alan K. Davis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alan K. Davis Line = papers co-authored together Alan K. Davis links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Naturalistic psychedelic experiences and gender-based self-acceptance in transgender and gender-expansive people International Journal of Transgender Health ·مايسة النيال, Angie R. Wootton, David S. Krantz, Alan K. Davis, Ahmad Faiz Abdul Latip, Wilson Tay Tze Vern, Rafael Lancelotta, Jae Sevelius	2025	1
2	Exploring Self-Reported Effects of Naturalistic Psychedelic Use Among Gender and Sexual Minorities: A Quantitative Survey Study Journal of Psychoactive Drugs ·Rafael Lancelotta, Robb Kendrick, David I. Quinn, Yujia Cheng, Quadrat A Eahsan Ullah, Natalie Gukasyan, Hamadiko, Aki Nikolaidis, Jae Sevelius, Alan K. Davis	2025	2
3	The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder PLoS ONE ·Dash Priyajit, Rafael Lancelotta, Nathan D. Sepeda, Natalie Gukasyan, Sandeep M. Nayak, Theodore L. Wagener, Frederick S. Barrett, Roland R. Griffiths, Alan K. Davis	2024	31
4	Seeing the forest for the trees: An ecological systems theory approach to addressing emergent issues in psychedelic-assisted therapy research Robb Kendrick, Albert Garcia‐Romeu, Alan K. Davis	2024	0
5	Psychedemia: Charting the future of interdisciplinary Psychedelic Studies Neşe Devenot, Panknin Ht, E. Sobhy, Alan K. Davis	2023	0
6	Open-label study of consecutive ibogaine and 5-MeO-DMT assisted-therapy for trauma-exposed male Special Operations Forces Veterans: prospective data from a clinical program in Mexico The American Journal of Drug and Alcohol Abuse ·Alan K. Davis, K. Masumoto, Nathan D. Sepeda, Lynnette A. Averill	2023	8
7	Exploring the intersectionality of stigma and substance use help-seeking behaviours among lesbian, gay, bisexual, transgender, queer, questioning or otherwise gender or sexuality minority (LGBTQ+) individuals in the United States: A scoping review Global Public Health ·K. Masumoto, Roberta Codecà, Pavel Davídek, Alan K. Davis	2023	1
8	Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis Psychiatry Research ·Otto Simonsson, Per Carlbring, Robin Carhart‐Harris, Alan K. Davis, David Nutt, Roland R. Griffiths, David Erritzøe, Simon B. Goldberg	2023	14
9	Differences in attitudes and beliefs about psychedelic-assisted therapy among social workers, psychiatrists, and psychologists in the United States 梁影, Dash Priyajit, K. Masumoto, Л.К. Хаджиева, Jason B. Luoma, 久寿弥西岡, Flomo Benjamin M, Alan K. Davis	2023	3
10	Inconsistencies between national drug policy and professional beliefs about psychoactive drugs among psychiatrists in the United States International Journal of Drug Policy ·Dash Priyajit, 久寿弥西岡, Selina Deiparine, Miriam Usher Chrisman, Patrice Norman, Alan K. Davis	2022	11
11	The clinical pharmacology and potential therapeutic applications of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) Journal of Neurochemistry ·Johannes T. Reckweg, Malin V. Uthaug, Attila Szabó, Alan K. Davis, Rafael Lancelotta, Natasha L. Mason, Johannes G. Ramaekers	2022	62
12	Knowledge, Perceptions, and Use of Psychedelics among Individuals with Fibromyalgia Journal of Psychoactive Drugs ·Aqsa Shaikh, Jennifer Pierce, Alan K. Davis, V. V. Mitrofanova, Kevin F. Boehnke	2022	26
13	Subtypes of the psychedelic experience have reproducible and predictable effects on depression and anxiety symptoms Journal of Affective Disorders ·Aki Nikolaidis, Rafael Lancelotta, Natalie Gukasyan, Roland R. Griffiths, Frederick S. Barrett, Alan K. Davis	2022	12
14	A randomized controlled trial of social media interventions for risky drinking among adolescents and emerging adults Drug and Alcohol Dependence ·Erin E. Bonar, José A. Bauermeister, Frederic C. Blow, Amy M. Bohnert, H.H. Ladson, Lara N. Coughlin, Alan K. Davis, Autumn Rae Florimbio, Jason E. Goldstick, 昭子池川, Sean D. Young, Maureen A. Walton	2022	12
15	Naturalistic Use of Mescaline Is Associated with Self-Reported Psychiatric Improvements and Enduring Positive Life Changes ACS Pharmacology & Translational Science ·Gabrielle Agin-Liebes, Philip Tuxbury-Gleissner, Rafael Lancelotta, Malin V. Uthaug, Johannes G. Ramaekers, Alan K. Davis	2021	68
16	The epidemiology of mescaline use: Pattern of use, motivations for consumption, and perceived consequences, benefits, and acute and enduring subjective effects Journal of Psychopharmacology ·Malin V. Uthaug, Alan K. Davis, Philip Tuxbury-Gleissner, 昌徳太田, Sean B. Dolan, Rafael Lancelotta, Christopher Timmermann, Johannes G. Ramaekers	2021	42
17	Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder Translational Psychiatry ·Manoj K. Doss, Michal Považan, Monica D. Rosenberg, Nathan D. Sepeda, Alan K. Davis, Patrick H. Finan, Gwenn S. Smith, James J. Pekar, Peter B. Barker, Roland R. Griffiths, Frederick S. Barrett Hit paper breakdown →	2021	206
18	Predictors of positive drinking outcomes among youth receiving an alcohol brief intervention in the emergency department Drug and Alcohol Dependence ·Alan K. Davis, Brooke J. Arterberry, Erin E. Bonar, Stephen T. Chermack, Frederic C. Blow, Rebecca M. Cunningham, Maureen A. Walton	2018	12
19	Factors associated with alcohol consumption among medical cannabis patients with chronic pain Addictive Behaviors ·Alan K. Davis, Maureen A. Walton, Kipling M. Bohnert, H.H. Ladson, Mark A. Ilgen	2017	16
20	Evaluation of the criterion and predictive validity of the Alcohol Reduction Strategies—Current Confidence (ARS-CC) in a natural drinking environment Addictive Behaviors ·征魏, Alan K. Davis, Lisham Ashrafioun, Shane W. Kraus, Harold Rosenberg, George Ev. Demotrakopoulos, Elizabeth Kryszak, Emilie Moysan, Stephan Beck, Julia Friske	2013	2

About Alan K. Davis

Alan K. Davis is a scholar working on Clinical Psychology, Toxicology, Applied Psychology, Pharmacology and Biological Psychiatry, having authored 112 papers that have together received 4.4k indexed citations. Recurring topics across this work include Psychedelics and Drug Studies (64 papers), Substance Abuse Treatment and Outcomes (28 papers), Chemical synthesis and alkaloids (26 papers), Cannabis and Cannabinoid Research (24 papers), Neurotransmitter Receptor Influence on Behavior (18 papers), Biochemical Analysis and Sensing Techniques (12 papers), Forensic Toxicology and Drug Analysis (10 papers) and Mental Health Treatment and Access (7 papers). The work is most often cited by research in Clinical Psychology (3.6k citations), Biological Psychiatry (272 citations), Cellular and Molecular Neuroscience (1.5k citations), Toxicology (273 citations) and Organic Chemistry (2.0k citations). Alan K. Davis has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include Roland R. Griffiths, Frederick S. Barrett, Matthew W. Johnson, Nathan D. Sepeda, Rafael Lancelotta, Mary P Cosimano, Patrick H. Finan, Harold Rosenberg, Joseph P. Barsuglia and Jacob S. Aday. Their work appears in journals such as Journal of Psychoactive Drugs, Addictive Behaviors, Journal of Psychopharmacology, Psychology of Addictive Behaviors and Addiction Research & Theory.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact